Adcock H1 revenue up 16%
South African pharmaceutical firm Adcock Ingram saw a 30 per cent rise in headline earnings per share for the six months ended December 31. It declared an interim of 104 cents per share. Joining CNBC Africa for more is Andy Hall, CEO of Adcock.
Wed, 23 Feb 2022 15:43:32 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.
